Metabolomes of mitochondrial diseases and inclusion body myositis patients: treatment targets and biomarkers

Metabolomes of mitochondrial diseases and inclusion body myositis patients: treatment targets and biomarkers

Abstract Mitochondrial disorders (MDs) are inherited multi‐organ diseases with variable phenotypes. Inclusion body myositis (IBM), a sporadic inflammatory muscle disease, also shows mitochondrial dysfunction. We investigated whether primary and secondary MDs modify metabolism to reveal pathogenic pa...

Full description

Bibliographic Details
Main Authors: Jana Buzkova, Joni Nikkanen, Sofia Ahola, Anna H Hakonen, Ksenia Sevastianova, Topi Hovinen, Hannele Yki‐Järvinen, Kirsi H Pietiläinen, Tuula Lönnqvist, Vidya Velagapudi, Christopher J Carroll, Anu Suomalainen
Format: Article
Language:English
Published: Wiley 2018-12-01
Series:EMBO Molecular Medicine
Subjects:
biomarker
inclusion body myositis
metabolomics
mitochondrial diseases
Online Access:https://doi.org/10.15252/emmm.201809091

Internet

https://doi.org/10.15252/emmm.201809091

Similar Items